Table 4 Calculated GI% for target compounds, in series (A) and (B) at (10−5 M) concentration, concerning the most sensitive NCI cancer cell lines.

From: Synthesis and anticancer activity of new benzensulfonamides incorporating s-triazines as cyclic linkers for inhibition of carbonic anhydrase IX

Compounda

Subpanel/cell line

CNS cancer (SNB-75)

Renal cancer (UO-31)

Breast cancer (MDA-MB-468)

Leukemia (SR)

5a

29

5b

28

11

5c

35

11

6a

19

18

13

6b

28

6c

21

16

6d

30

12

6e

11

6f.

23

11

6g

33

14

6h

17

6i

14

6j

29

17

7a

12

8a

14

17

8b

21

11

15

8c

10

33

12a

12b

14

16

16

14

12c

14

22

16

12d

12

14

62

51

12e

13

27

11

12f.

10

15

15

11

12g

15

11

11

12h

11

27

12i

20

17

12j

11

14

  1. aOnly GI% ≥ 10% are shown.